Similar to MAS, patients with a gain-of-function mutation in NLRC4 (58) or deficiency in X-linked inhibitor of apoptosis (XIAP) (41) also experience a life-threatening hyper-inflammatory state with high levels of free IL-18. Here, IL18 is linked to macrophage activation syndrome.